# ELITEK
> **BLA103946** · Biologics License Application · Sponsor: SANOFI SYNTHELABO · Approved 2002-07-12
## Drug
- **FDA Application Number:** BLA103946
- **Application type:** Biologics License Application
- **Brand name:** ELITEK
- **Generic name:** RASBURICASE
- **Active ingredients:** RASBURICASE
- **Dosage form:** VIAL
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** SANOFI SYNTHELABO
- **Manufacturer:** Sanofi-Aventis U.S. LLC
- **First approval:** 2002-07-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103946)
---
*AI Analytics · CC0 1.0*